Summary
The product Arimimed, manufactured by Deus Medical, was analyzed to verify its content and dosage consistency. The sample, identified by batch number DM37892 with a manufacturing date of October 2020, underwent quantitative and qualitative analysis by Janoshik Analytical. The analysis confirmed the presence of Anastrozole with measured concentrations of 1.03 mg and 1.04 mg in two pills, closely aligning with the labeled claim of 1 mg per pill.
The testing was conducted on 2 December 2020, with both submission and analysis completed on the same day. The sample was submitted and paid for by a reseller, DEUSPOWER.SHOP. The results demonstrate a high level of dosage accuracy, reflecting a minimal variance from the label claim, reinforcing the product’s reliability.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: Arimimed
- Active Ingredient: Anastrozole
- Batch Number: DM37892
- Manufacture Date: October 2020
- Delivery Method: Oral tablet
Sample Acquisition and Testing
- Task Number: #09247
- Testing Ordered: 2 December 2020
- Sample Received: 2 December 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.SHOP (Reseller)
- Analysis Paid For By: DEUSPOWER.SHOP (Reseller)
Testing Results
- Specification: 1 mg of Anastrozole per pill (as stated on the label)
- Measured Concentration in First Pill: 1.03 mg
- Measured Concentration in Second Pill: 1.04 mg
- Accuracy: 103% and 104% of the label claim
Verification Details
- Verification URL: https://janoshik.com/tests/09247_BU4LYZNCCL2I
- Originally Published: https://thinksteroids.com/community/forums/analytical-lab-testing/
Evaluation of Reseller-Funded Testing
The test was both submitted and funded by DEUSPOWER.SHOP, a reseller, which necessitates an acknowledgment of potential bias. Reseller-funded testing may involve sample selection aimed at showcasing optimal results. However, Janoshik Analytical’s history of transparency and adherence to rigorous testing standards lends credibility to the findings. Cross-referencing these results with independent testing is recommended for enhanced confidence.
Conclusion
The analysis confirms that Arimimed 1 by Deus Medical delivers accurate dosages of Anastrozole, with both tested pills measuring marginally above the labeled claim. The findings underscore the product’s consistency and quality, offering valuable information for consumers and healthcare professionals focused on harm reduction.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
